文献速递免疫规划

口服衣原体疫苗接种在小鼠气道诱导跨黏膜保护

Oral Chlamydia vaccination induces transmucosal protection in the airway.
PubMed 文献 · Vaccine · 2018-03-14

研究显示,单次口服免疫小鼠衣原体(Chlamydia muridarum)可诱导跨黏膜免疫,使小鼠气道在随后经鼻攻毒后衣原体载量显著降低,并完全阻止气道向气道外组织播散,免疫小鼠未出现显著体重下降,保护与衣原体特异性抗体及以Th1为主的T细胞应答相关。

要点

  • 单次口服C. muridarum免疫在小鼠气道诱导了跨黏膜保护。
  • 口服免疫显著降低攻毒后第3天气道衣原体载量,第3天完全阻止、第9天显著减少气道外播散。
  • 保护与识别衣原体表面抗原的特异性抗体及Th1优势T细胞应答相关。

核心结论

  • 口服接种C. muridarum可诱导小鼠气道Th1优势的跨黏膜免疫并提供保护。
  • 作者提出,胃肠道内非致病性衣原体定植可作为口服递送系统加以探索,以诱导针对胃肠道外组织感染和病理的保护。

研究设计与样本

  • 小鼠经单次口服免疫C. muridarum后,接受经鼻攻毒感染,评估气道衣原体载量、气道外组织播散、体重变化及免疫应答。

主要发现

  • 口服免疫显著降低经鼻攻毒后第3天气道衣原体载量。
  • 气道衣原体向气道外组织播散在第3天被完全阻止,第9天显著减少。
  • 免疫小鼠未出现显著体重下降。
  • 保护与识别衣原体表面抗原的特异性抗体及以Th1为主的T细胞应答相关,免疫小鼠IgG2b/c与IgG1比值高、产IFNγ与产IL-5或IL-13淋巴细胞比值高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although Chlamydia has been frequently detected in the gastrointestinal tracts of both humans and animals, it is not associated with any gastrointestinal pathology. We have recently shown that gastrointestinal Chlamydiamuridarum is not only non-pathogenic but also induces protective immunity in the genital tract. We now report that the transmucosal immunity induced by a single oral immunization with C.muridarum protected the mouse airway from a subsequent challenge infection. The oral immunization significantly reduced chlamydial burden in the airway as early as day 3 after intranasal challenge. As a result, the airway chlamydial spreading to extra-airway tissues was completely prevented on day 3 and significantly reduced on day 9. The immunized mice were protected from any significant systemic toxicity caused by the intranasal challenge since there was no significant bodyweight drop in the immunized mice. This robust protection correlated well with Chlamydia-specific antibodies that recognize chlamydial organism surface antigens and T cell responses that are dominated with a Th1 phenotype. The immunized mice developed high ratios of IgG2b/c over IgG1 levels and IFNγ-producing over IL-5- or IL-13-producing lymphocytes. Thus, we have demonstrated that oral vaccination with C. muridarum can induce Th1-dominant transmucosal immunity in the airway. Together with previous studies, we propose that non-pathogenic colonization of Chlamydia in the gastrointestinal tract be explored as an oral delivery system for inducing protection against infections and pathologies in extra-gastrointestinal tissues.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Zhu C, Lin H, Tang L, et al. Oral Chlamydia vaccination induces transmucosal protection in the airway. Vaccine. 2018. PMID: 29550196. doi:10.1016/j.vaccine.2018.03.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。